TuisALM • VIE
add
Almirall SA
Vorige sluiting
€9,65
Dagwisseling
€9,70 - €9,72
Jaarwisseling
€8,09 - €10,42
Markkapitalisasie
2,06 mjd EUR
Gemiddelde volume
45,00
P/V-verhouding
202,33
Dividend-opbrengs
1,89%
Primêre beurs
BME
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 259,43 m | 16,71% |
Bedryfskoste | 262,77 m | 17,51% |
Netto inkomste | 2,95 m | 105,66% |
Netto winsgrens | 1,14 | 104,87% |
Wins per aandeel | — | — |
EBITDA | 31,54 m | 99,77% |
Effektiewe belastingkoers | 240,20% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 377,30 m | -2,78% |
Totale bates | 2,40 mjd | 0,91% |
Totale aanspreeklikheid | 908,28 m | -0,36% |
Totale ekwiteit | 1,49 mjd | — |
Uitstaande aandele | 213,47 m | — |
Prys om te bespreek | 1,38 | — |
Opbrengs op bates | 1,33% | — |
Opbrengs op kapitaal | 1,69% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 2,95 m | 105,66% |
Kontant van bedrywe | 54,67 m | 26,00% |
Kontant van beleggings | -16,14 m | -116,09% |
Kontant van finansiering | -4,58 m | 19,51% |
Netto kontantverandering | 33,94 m | -75,41% |
Beskikbare kontantvloei | -20,77 m | -116,04% |
Meer oor
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Gestig
1944
Webwerf
Werknemers
2 026
